Literature DB >> 30482953

Cancer: Redirecting T cell activity in solid tumours.

Sarah Crunkhorn.   

Abstract

Entities:  

Year:  2018        PMID: 30482953     DOI: 10.1038/nrd.2018.214

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Avidity-based binding to HER2 results in selective killing of HER2-overexpressing cells by anti-HER2/CD3.

Authors:  Dionysos Slaga; Diego Ellerman; T Noelle Lombana; Rajesh Vij; Ji Li; Maria Hristopoulos; Robyn Clark; Jennifer Johnston; Amy Shelton; Elaine Mai; Kapil Gadkar; Amy A Lo; James T Koerber; Klara Totpal; Rodney Prell; Genee Lee; Christoph Spiess; Teemu T Junttila
Journal:  Sci Transl Med       Date:  2018-10-17       Impact factor: 17.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.